vcf contraceptive- nonoxynol-9 film, soluble
apothecus pharmaceutical corp. - nonoxynol-9 (unii: 48q180sh9t) (nonoxynol-9 - unii:48q180sh9t) - vaginal contraceptive for the prevention of pregnancy
vcf contraceptive- nonoxynol-9 aerosol, foam
apothecus pharmaceutical corp - nonoxynol-9 (unii: 48q180sh9t) (nonoxynol-9 - unii:48q180sh9t) - vaginal contraceptive for the prevention of pregnancy
leader emergency contraceptive levonorgestrel- levonorgestrel tablet
cardinal health 110, llc. dba leader - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw) - emergency contraceptive for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control)
multiload cu each
infar - contraceptive device - intrauterine copper contraceptive device prviding copper surface area of 250sq. mm - each
multiload cu each
infar - contraceptive device - intrauterine copper contraceptive device prviding copper surface area of 375sq. mm - each
implanon nxt etonogestrel 68mg subcutaneous implant
organon pharma pty ltd - etonogestrel, quantity: 68 mg - implant - excipient ingredients: magnesium stearate; barium sulfate; vinyl acetate; octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate; isododecane; ethylene/vinyl acetate copolymer - contraception (removed and replaced every three years to ensure continued contraceptive efficacy)
harmonet
pfizer pfe pharmaceuticals israel ltd - ethinylestradiol; gestodene - coated tablets - ethinylestradiol 0.020 mg; gestodene 0.075 mg - gestodene and estrogen - gestodene and estrogen - contraceptive.
nuvaring
organon pharma israel ltd., israel - ethinylestradiol; etonogestrel - vaginal ring - ethinylestradiol 2.7 mg; etonogestrel 11.7 mg - ethinylestradiol - ethinylestradiol - contraception. the safety and efficacy has been established in women aged 18 to 40 years.
cilest 35/ 250 micrograms film-coated tablets
janssen-cilag ltd - norgestimate, ethinylestradiol - film-coated tablet - 35/ 250 micrograms - hormonal contraceptives for systemic use; progestogens and estrogens, fixed combinations - contraception and the recognised indications for such estrogen/progestogen combinations
nuvaring
organon pharma israel ltd., israel - ethinylestradiol; etonogestrel - vaginal ring - ethinylestradiol 2.7 mg; etonogestrel 11.7 mg - ethinylestradiol - contraception. the safety and efficacy has been established in women aged 18 to 40 years.